Trademarkia Logo

Australia

AU$
OMZUVI
Cancelled: Cancelled at the request of IB

Last updated on 9 May 2021

Owner Info

Recro Pharma, Inc.

490 Lapp Road

Malvern PA 19355, UNITED STATES OF AMERICA

Serial Number

1838225 filed on 20 Jan 2017

Correspondent

Pepper Hamilton LLP

The New York Times Building,,

37th Floor,,

UNITED STATES OF AMERICA

OMZUVI

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of pain

Mark Details


Serial Number

1838225

Registered On

20 Jan 2017

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

2 Nov 2016

Mark Type

US

Legal History


Show more

Status DateAction Taken
9th May 2021Status change to Voided
18th Jun 2020Amendment to International Registration Contact Requested
17th Apr 2020Customer Amendment Made correspondence sent
9th Apr 2020Amendment to Address for Service Requested
10th Aug 2017IP Right Registration Published
2th Aug 2017Register Trade Mark
2th Aug 2017Application Status
1st Jun 2017Amendment to Application/Registration
25th May 2017IP Right Acceptance Published
17th May 2017Clear Examination report approved